Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice.
AUTOR(ES)
McKendall, R R
RESUMO
ICR mice were immunized with herpes simplex virus type 1 (HSV-1) and later challenged with HSV-2 by footpad inoculation. Both immunized animals and age-matched, nonimmunized controls were observed for ascending neurological disease and latent infection of spinal ganglia resulting from the HSV-2 challenge. Control animals had a 78% incidence of acute and latent infection compared with a 1.7% incidence in immunized mice. The data show immunity to HSV-1 is protective against both acute and latent infection by HSV-2.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=421016Documentos Relacionados
- Detection of herpes simplex virus type 1 transcripts during latent infection in mice.
- Xylotubercidin against herpes simplex virus type 2 in mice.
- Interleukin-18 Protects Mice against Acute Herpes Simplex Virus Type 1 Infection
- Detection of Herpes Simplex Virus Type 1 Transcripts During Latent Infection in Mice
- Efficacy of 2'-nor-2'-deoxyguanosine treatment for orofacial herpes simplex virus type 1 skin infections in mice.